重松貿易 Product Lineup

Cytoart is a company located in Arizona, USA, that has product technology for the detection of CAR-T cells using flow cytometry. The sensitivity and accuracy of the company's products are exceptional, making them useful for the development, quality control, and clinical monitoring of CAR-T cell therapy. The manufacturer of the products is BioSwan Laboratories, Inc., which is responsible for sales and marketing. 【Products Offered (Partial)】 ■ Rabbit Anti-Mouse FMC63 scFv Monoclonal Antibody (R19M) (100 tests) ■ Rabbit Anti-Mouse FMC63 scFv Monoclonal Antibody (R19M) (1 mg) ■ Rabbit Anti-Mouse FMC63 scFv Monoclonal Antibody (R19M), Alexa Fluor 647 (25 tests) *You can download the English version of the catalog. For more details, please feel free to contact us.

We would like to introduce the CAR-T cell detection products offered by Cytoart. The generation of CAR-T cells requires the transfection of CAR genes into T cells via viral or non-viral systems. The CAR-positive T cells that express CAR on their membrane have the ability to recognize and damage target cells, making the detection of CAR-positive T cells a crucial step in the quality control of CAR-T cell therapy, as well as an important criterion for managing clinical doses, process monitoring, and diagnostic assistance. Cytoart's antibody development platform focuses on targeting the scFV region on CAR-T cells. Advantages of using scFV for target detection in CAR-T cell therapy: - High specificity: Ensures accurate target binding and reduces off-target complications. - Sensitivity: The detection of targets using scFV allows for real-time monitoring of the activity and distribution of low levels of CAR-T cells in samples. - Versatility: scFV target detection can be applied to various types of research related to CAR-T cells.